The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET ANALYSIS: Looming Trump Decision On Iran Deal May Weigh On Wall Street

Tue, 08th May 2018 13:58

WASHINGTON (Alliance News) - The major US index futures are pointing to a lower opening on Tuesday, with stocks likely to give back ground after ending the previous session mostly higher.

Geopolitical concerns may weigh on the markets ahead of President Donald Trump's announcement of his decision on the Iran nuclear deal.

Trump is widely expected to withdraw from the agreement, which lifted sanctions on Iran in exchange for limits on the country's nuclear program.

Overall trading activity may be somewhat subdued, however, as a lack of major US economic data may keep some traders on the sidelines.

After an early move to the upside, stocks gave back ground in afternoon trading on Monday but managed to end the day higher. With the gains on the day, the major averages extended the rally seen in the previous session.

The Dow rose 94.81 points or 0.4% to 24,357.32, the Nasdaq advanced 55.60 points or 0.8% to 7,265.23 and the S&P 500 climbed 9.21 points or 0.4% to 2,672.63.

Stocks initially continued to benefit from the upward momentum seen last Friday in response to the Labor Department's monthly jobs report.

While the report showed weaker than expected job growth in the month of April, the unemployment rate fell to its lowest level since 2000.

The jobs report reinforced expectations that the Federal Reserve will raise interest rates next month, although subdued wage growth has led traders to believe the Fed will not increase rates too aggressively.

The pullback seen in afternoon trading came as President Donald Trump announced via Twitter that he will reveal his decision on the Iran nuclear deal on Tuesday.

Computer hardware, biotechnology and brokerage stocks saw significant strength on the day, while telecom and tobacco stocks showed notable moves to the downside.

Commodity, Currency Markets

Crude oil futures are falling USD0.64 to USD70.09 a barrel after jumping USD1.01 to USD70.73 a barrel on Monday. Meanwhile, after slipping USD0.60 to USD1,314.10 an ounce in the previous session, gold futures are dropping USD2.40 to USD1,311.70 an ounce.

On the currency front, the US dollar is trading at 109.07 yen compared to the 109.09 yen it fetched at the close of New York trading on Monday. Against the euro, the dollar is valued at USD1.1872 compared to yesterday's USD1.1922.

Asia

Asian stocks ended mostly higher on Tuesday as Chinese trade data topped forecasts and investors awaited an announcement by President Donald Trump on whether he will withdraw from the nuclear deal with Iran.

China's Shanghai Composite Index climbed 24.95 points or 0.8% to 3,161.60 after the release of upbeat trade figures for April. Hong Kong's Hang Seng Index surged up 408.55 points or 1.4% to 30,402.81.

Chinese exports climbed 12.9% year-over-year in April, well above the expected rise of 6.8%. Imports spiked 21.5% from a year ago, exceeding economists' forecast for an increase of 15.9%. The trade surplus totaled USD28.8 billion in April versus the expected surplus of USD25.7 billion.

Japanese shares recovered from a weak start to end modestly higher, led by banks and drug makers. The benchmark Nikkei 225 Index gained 41.53 points or 0.2% to end at 22,508.69, while the broader Topix Index closed 0.4% higher at 1,779.82.

Lender Mitsubishi UFJ Financial rose 0.9%, Sumitomo Mitsui Financial inched up 0.4% and Mizuho Financial Group gained 0.6%. Takeda Pharmaceutical Company soared 4% ahead of its announcement to buy larger rival Shire for USD62.42 billion.

On the data front, average household spending in Japan fell 0.7% year-on-year in March, the Ministry of Internal Affairs and Communications said, coming in at 301,230 yen. That missed forecasts for an increase of 1.1%.

Australian shares ended marginally higher, led by financials as Australia and New Zealand Banking Group flagged the likelihood of an additional buyback of shares to the tune of USD1 billion-$1.5 billion.

Investors also waited for the release of the annual budget amid expectations the government will announce hefty health and infrastructure spending and deliver tax cuts targeting lower and middle-income earners.

Meanwhile, market participants shrugged off soft retail sales figures for March. Retail sales remained flat in March, defying economists' forecast for an increase.

The benchmark S&P/ASX 200 Index inched up 7.40 points or 0.1% to 6,091.90, while the broader All Ordinaries Index ended 7.60 points higher at 6,183.20.

ANZ shares rose over 1%, Commonwealth advanced 1.1% and Westpac added 1.3%. Investment bank Macquarie Group rallied 1.7% to extend gains for the fourth straight session.

Healthscope jumped 3.3% after Canada's NorthWest Healthcare Properties REIT said it has taken a 10% interest in the company. Biotherapeutics company CSL climbed 1.5%.

Meanwhile, Beach Energy, Origin Energy, Woodside Petroleum and Santos dropped 1-2% as oil prices retreated from three-and-a-half-year highs ahead of Trump's decision on Iran.

Europe

European stocks are mostly lower on Tuesday even as UK markets held somewhat steady, helped by a weakening pound and deal-making news.

While the UK's FTSE 100 Index is just below the unchanged line, the French CAC 40 Index is down by 0.5% and the German DAX Index is down by 0.7%.

On the data front, reports on German industrial output, exports and UK house prices painted a mixed picture of regional economies.

Cement giant LafargeHolcim has moved lower after its first-quarter recurring EBITDA fell 7.7% on a like-for-like basis, affected by the especially harsh winter in North America and Europe.

Adecco Group has also tumbled. The staffing firm's first-quarter net income fell 26% due to one-offs and investments.

Danish hearing aid maker William Demant Holding has plummeted after warning of lower revenue.

Deutsche Post shares have also slumped. The German postal and logistics group confirmed its 2018 targets after reporting a fall in first-quarter consolidated net profit.

On the positive side, consumer products giant Unilever has rallied after commencing the first tranche of its share buyback program.

Shire PLC shares have also jumped in London after Japan's Takeda Pharmaceutical announced it had reached an agreement on the terms of a recommended offer to acquire the Irish drugmaker.

Similarly, Virgin Money Holdings has soared after receiving a preliminary and conditional proposal from CYBG.

US Economic Reports

At 1 pm ET, the Treasury Department is scheduled to announce the results of its auction of USD31 billion worth of three-year notes.

Stocks In Focus

Shares of Dish Network (DISH) are moving lower in pre-market trading after the satellite TV provider reported first quarter earnings that matched analyst estimates but on weaker than expected revenues.

Fertilizer producer Mosaic (MOS) may also see early weakness after reporting first quarter earnings that came in below expectations.

Shares of Hertz Global (HTZ) is also likely to come under pressure after the car rental company reported a wider than expected first quarter loss.

On the other hand, shares of Dean Foods (DF) are moving sharply higher in pre-market trading after the dairy producer reported better than expected first quarter results.

Drug maker Valeant Pharmaceuticals (VRX) may also see early strength after reporting first quarter revenues that exceeded estimates and raised its full-year guidance.

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.